|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's Range||11.85 - 12.31|
|52 Week Range||7.80 - 18.35|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.90|
We can readily understand why investors are attracted to unprofitable companies. For example, although...
NEW YORK & LONDON & HONG KONG, January 11, 2023--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the "Board") had appointed Michael Spellacy, as Board Chair, effective immediately.
Taking the occasional loss comes part and parcel with investing on the stock market. Unfortunately, shareholders of...